Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model
Authors
Keywords
Osteosarcoma, <em class=EmphasisTypeItalic >LSAMP</em>, Tumor suppressor, <em class=EmphasisTypeItalic >LSAMP-AS1</em>, <em class=EmphasisTypeItalic >LSAMP-AS3</em>, <em class=EmphasisTypeItalic >LSAMP-AS4</em>, Deletion 3q13.31, Proliferation, Tumor formation
Journal
Molecular Cancer
Volume 13, Issue 1, Pages 93
Publisher
Springer Nature
Online
2014-04-29
DOI
10.1186/1476-4598-13-93
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes
- (2013) S U Lauvrak et al. BRITISH JOURNAL OF CANCER
- Low expression of LOC285194 is associated with poor prognosis in colorectal cancer
- (2013) Peng Qi et al. Journal of Translational Medicine
- LncRNA loc285194 is a p53-regulated tumor suppressor
- (2013) Qian Liu et al. NUCLEIC ACIDS RESEARCH
- High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterations
- (2012) M. W. M. Kuhn et al. BLOOD
- Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data
- (2012) Marieke L. Kuijjer et al. GENES CHROMOSOMES & CANCER
- Combinatorial Treatment of DNA and Chromatin-Modifying Drugs Cause Cell Death in Human and Canine Osteosarcoma Cell Lines
- (2012) Venugopal Thayanithy et al. PLoS One
- Modulation of the Osteosarcoma Expression Phenotype by MicroRNAs
- (2012) Heidi M. Namløs et al. PLoS One
- Integrative Analysis Reveals Relationships of Genetic and Epigenetic Alterations in Osteosarcoma
- (2012) Stine H. Kresse et al. PLoS One
- Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents
- (2011) E. P. Buddingh et al. CLINICAL CANCER RESEARCH
- Functional characterization of osteosarcoma cell lines provides representative models to study the human disease
- (2011) Alexander B Mohseny et al. LABORATORY INVESTIGATION
- TGF-β Inducible Early Gene 1 Regulates Osteoclast Differentiation and Survival by Mediating the NFATc1, AKT, and MEK/ERK Signaling Pathways
- (2011) Muzaffer Cicek et al. PLoS One
- Adipocyte Differentiation of Human Bone Marrow-Derived Stromal Cells Is Modulated by MicroRNA-155, MicroRNA-221, and MicroRNA-222
- (2011) Magne Skårn et al. STEM CELLS AND DEVELOPMENT
- Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy
- (2010) Bekim Sadikovic et al. BMC CANCER
- Recurrent Focal Copy-Number Changes and Loss of Heterozygosity Implicate Two Noncoding RNAs and One Tumor Suppressor Gene at Chromosome 3q13.31 in Osteosarcoma
- (2010) I. Pasic et al. CANCER RESEARCH
- Genomic Alterations and Allelic Imbalances Are Strong Prognostic Predictors in Osteosarcoma
- (2010) J. Smida et al. CLINICAL CANCER RESEARCH
- LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization
- (2009) Stine H. Kresse et al. GENES CHROMOSOMES & CANCER
- Notch signaling contributes to the pathogenesis of human osteosarcomas
- (2009) F. Engin et al. HUMAN MOLECULAR GENETICS
- Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH
- (2008) S. Selvarajah et al. CYTOGENETIC AND GENOME RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started